Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Status:
Completed
Trial end date:
2018-11-02
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of multiple dose levels of NYX-2925 versus placebo in treating the
neuropathic pain associated with Diabetic Peripheral Neuropathy.